name:-0.038944005966187
name:-0.042427778244019
name:-0.00047802925109863
Newron Pharmaceuticals S.p.A. Patent Filings

Newron Pharmaceuticals S.p.A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Newron Pharmaceuticals S.p.A..The latest application filed is for "process for the production of substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives".

Company Profile
0.48.38
  • Newron Pharmaceuticals S.p.A. - Bresso (Milano) IT
  • Newron Pharmaceuticals S.p.A. - Bresso (Milan) N/A IT
  • NEWRON PHARMACEUTICALS S.P.A. - Bresso N/A IT
  • NEWRON PHARMACEUTICALS S.P.A. - Bresso MI
  • Newron Pharmaceuticals S.P.A.; - US
  • Newron Pharmaceuticals S.p.A. - Brosse MI
  • Newron Pharmaceuticals S.P.A - Bresso IT
  • Newron Pharmaceuticals S.p.A. - MI
  • Newron Pharmaceuticals SpA - Bresso (Mi) IT
  • Newron Pharmaceuticals, S.p.A. - Milan IT
  • NEWRON PHARMACEUTICALS S.P.A. - VIA L. ARIOSTO, 21 BRESSO IT
  • Newron Pharmaceuticals S.p.A. - Gerenzano IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Process For The Production Of Substituted 2-[2-(phenyl)ethylamino]alkaneamide Derivatives
App 20220185766 - Leong; William ;   et al.
2022-06-16
Process For The Production Of Substituted 2-[2-(phenyl) Ethylamino]alkaneamide Derivatives
App 20220177417 - Skranc; Wolfgang ;   et al.
2022-06-09
Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
Grant 9,856,207 - Giordano , et al. January 2, 2
2018-01-02
Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,603,832 - Melloni , et al. March 28, 2
2017-03-28
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,585,869 - Melloni , et al. March 7, 2
2017-03-07
Process For The Production Of Ralfinamide Salts Substantially Free From Impurities Having Genotoxic Effects
App 20170029365 - Giordano; Claudio ;   et al.
2017-02-02
Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
Grant 9,505,708 - Giordano , et al. November 29, 2
2016-11-29
Fluorinated Arylalkylaminocarboxamide Derivatives
App 20160332959 - Pevarello; Paolo
2016-11-17
Methods for treatment of Parkinson's disease
Grant 9,492,410 - Fariello , et al. November 15, 2
2016-11-15
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,474,737 - Melloni , et al. October 25, 2
2016-10-25
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,474,738 - Melloni , et al. October 25, 2
2016-10-25
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,474,739 - Melloni , et al. October 25, 2
2016-10-25
Fluorinated arylalkylaminocarboxamide derivatives
Grant 9,447,029 - Pevarello September 20, 2
2016-09-20
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,248,116 - Melloni , et al. February 2, 2
2016-02-02
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20150157600 - Melloni; Piero ;   et al.
2015-06-11
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20150157602 - Melloni; Piero ;   et al.
2015-06-11
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20150157599 - Melloni; Piero ;   et al.
2015-06-11
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20150157598 - Melloni; Piero ;   et al.
2015-06-11
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20150157601 - Melloni; Piero ;   et al.
2015-06-11
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 9,051,240 - Melloni , et al. June 9, 2
2015-06-09
Methods For Treatment of Parkinson's Disease
App 20150150833 - Fariello; Ruggero ;   et al.
2015-06-04
Methods for treatment of Parkinson's disease
Grant 8,901,176 - Fariello , et al. December 2, 2
2014-12-02
High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
Grant 8,846,763 - Barbanti , et al. September 30, 2
2014-09-30
Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
Grant 8,741,957 - Salvati , et al. June 3, 2
2014-06-03
Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use
Grant 8,710,040 - Salvati , et al. April 29, 2
2014-04-29
Alpha-aminoamide derivatives useful in the treatment of addictive disorders
Grant 8,697,738 - Besana , et al. April 15, 2
2014-04-15
Fluorinated Arylalkylaminocarboxamide Derivatives
App 20140088074 - Pevarello; Paolo
2014-03-27
High Purity 2-[4-(3- Or 2-fluorobenzyloxy)benzylamino] Propanamides And Methods Of Use Thereof
App 20140051758 - BARBANTI; Elena ;   et al.
2014-02-20
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20130289122 - MELLONI; Piero ;   et al.
2013-10-31
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20130274249 - MELLONI; Piero ;   et al.
2013-10-17
High purity 2-[4-(3- OR 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof
Grant 8,530,701 - Barbanti , et al. September 10, 2
2013-09-10
Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
Grant 8,519,000 - Melloni , et al. August 27, 2
2013-08-27
Alpha-aminoamide Derivatives Useful In The Treatment Of Restless Legs Syndrome
App 20130217747 - Besana; Claudia ;   et al.
2013-08-22
2-phenylethylamino derivatives as calcium and/or sodium channel modulators
Grant 8,470,877 - Thaler , et al. June 25, 2
2013-06-25
.alpha.-Aminoamide derivatives useful in the treatment of restless legs syndrome
Grant 8,445,513 - Besana , et al. May 21, 2
2013-05-21
Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
Grant 8,445,539 - Izzo , et al. May 21, 2
2013-05-21
Methods For Treatment Of Parkinson's Disease
App 20130053368 - Ruggero; Fariello ;   et al.
2013-02-28
Process For The Production Of Ralfinamide Salts Substantially Free From Impurities Having Genotoxic Effects
App 20130039983 - Giordano; Claudio ;   et al.
2013-02-14
Methods for treatment of parkinson's disease
Grant 8,283,380 - Fariello , et al. October 9, 2
2012-10-09
Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
Grant 8,278,485 - Barbanti , et al. October 2, 2
2012-10-02
2-phenylethylamino Derivatives As Calcium And/or Sodium Channel Modulators
App 20120220592 - THALER; Florian ;   et al.
2012-08-30
Process For The Production Of 2-[4-(3- And 2-fluorobenzyloxy) Benzylamino] Propanamides
App 20120157712 - BARBANTI; ELENA ;   et al.
2012-06-21
Pharmaceutical Composition Comprising Gabapentin Or An Analogue Thereof And An Alpha-aminoamide And Its Analgesic Use
App 20120142777 - SALVATI; PATRICIA ;   et al.
2012-06-07
2-phenylethylamino derivatives as calcium and/or sodium channel modulators
Grant 8,129,427 - Thaler , et al. March 6, 2
2012-03-06
Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use
Grant 8,084,447 - Salvati , et al. December 27, 2
2011-12-27
Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
Grant 8,076,515 - Barbanti , et al. December 13, 2
2011-12-13
3-aminopyrrolidone derivatives
Grant 8,063,039 - Thaler , et al. November 22, 2
2011-11-22
Use Of (halobenzyloxy) Benzylamino-propanamides For The Manufacture Of Medicaments Active As Sodium And/or Calcium Channel Selective Modulators
App 20110184068 - Barbanti; Elena ;   et al.
2011-07-28
3-aminopyrrolidone derivatives
Grant 7,968,592 - Thaler , et al. June 28, 2
2011-06-28
2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators
App 20110046129 - Thaler; Florian ;   et al.
2011-02-24
Alpha-aminoamide Derivatives Useful In The Treatment Of Psychiatric Disorders
App 20110014304 - Izzo; Emanuela ;   et al.
2011-01-20
High Purity 2-[4-(3- Or 2-fluorobenzyloxy)benzylamino]propanamides And Methods Of Use Thereof
App 20100324141 - Barbanti; Elena ;   et al.
2010-12-23
2-phenylethylamino derivatives as calcium and/or sodium channel modulators
Grant 7,855,227 - Thaler , et al. December 21, 2
2010-12-21
Methods of treating disorders of trigeminalvascular activation
App 20100267835 - Salvati; Patricia ;   et al.
2010-10-21
Substituted 2-[2-(phenyl) Ethylamino] Alkaneamide Derivatives And Their Use As Sodium And/or Calcium Channel Modulators
App 20100210631 - Melloni; Piero ;   et al.
2010-08-19
Hydroxylamine Derivatives
App 20100197799 - CACCIA; Carla ;   et al.
2010-08-05
Hydroxylamine derivatives
Grant 7,763,751 - Caccia , et al. July 27, 2
2010-07-27
Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
Grant 7,718,815 - Barbanti , et al. May 18, 2
2010-05-18
Alpha-aminoamide derivatives useful as antimigraine agents
Grant 7,709,523 - Salvati , et al. May 4, 2
2010-05-04
3-aminopyrrolidone Derivatives
App 20100048665 - THALER; Florian ;   et al.
2010-02-25
Alpha-aminoamide Derivatives Useful As Anti-inflammatory Agents
App 20100016440 - Salvati; Patricia ;   et al.
2010-01-21
Substituted benzylaminoalkylene heterocycles
Grant 7,649,005 - Salvati , et al. January 19, 2
2010-01-19
Process For The Production Of 2-[4-(3- And 2-fluorobenzyloxy) Benzylamino] Propanamides
App 20090156678 - Barbanti; Elena ;   et al.
2009-06-18
Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives
App 20090005436 - Carotti; Angelo ;   et al.
2009-01-01
2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators
App 20080319057 - Thaler; Florian ;   et al.
2008-12-25
N-acyl-N'-benzyl-alkylendiamino derivatives
Grant 7,411,091 - Thaler , et al. August 12, 2
2008-08-12
(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
App 20080096965 - Barbanti; Elena ;   et al.
2008-04-24
Alpha-aminoamide derivatives useful as analgesic agents
Grant RE40,259 - Pevarello , et al. April 22, 2
2008-04-22
Cyclopentyl derivatives
Grant 7,265,244 - Melloni , et al. September 4, 2
2007-09-04
Substituted benzylaminoalkylene heterocycles
App 20070135496 - Salvati; Patricia ;   et al.
2007-06-14
Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract
App 20070112025 - Salvati; Patricia ;   et al.
2007-05-17
Alpha-aminoamide derivatives useful as analgesic agents
Grant 6,306,903 - Pevarello , et al. October 23, 2
2001-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed